Pictet Asset Management (UK)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $81.6M | Buy |
840,585
+75,564
| +10% | +$7.34M | 0.09% | 258 |
|
2021
Q1 | $52.3M | Buy |
765,021
+357,222
| +88% | +$24.4M | 0.06% | 318 |
|
2020
Q4 | $35M | Buy |
407,799
+201,943
| +98% | +$17.3M | 0.05% | 377 |
|
2020
Q3 | $13.4M | Buy |
205,856
+695
| +0.3% | +$45.2K | 0.02% | 496 |
|
2020
Q2 | $15M | Buy |
205,161
+58,403
| +40% | +$4.27M | 0.03% | 442 |
|
2020
Q1 | $4.99M | Sell |
146,758
-192,794
| -57% | -$6.56M | 0.01% | 636 |
|
2019
Q4 | $18.5M | Buy |
+339,552
| New | +$18.5M | 0.03% | 452 |
|
2018
Q3 | – | Sell |
-570,786
| Closed | -$22.6M | – | 976 |
|
2018
Q2 | $22.6M | Sell |
570,786
-24,432
| -4% | -$966K | 0.05% | 371 |
|
2018
Q1 | $15.3M | Buy |
595,218
+276,307
| +87% | +$7.12M | 0.04% | 426 |
|
2017
Q4 | $8.6M | Buy |
+318,911
| New | +$8.6M | 0.02% | 537 |
|